Suppr超能文献

影响同种异体角膜排斥反应治疗效果的因素。

Factors influencing outcomes of the treatment of allograft corneal rejection.

机构信息

Monash University, Melbourne, Australia.

The Chinese University of Hong Kong, Hong Kong; Centre for Eye Research Australia, University of Melbourne, East Melbourne, Australia.

出版信息

Am J Ophthalmol. 2011 Sep;152(3):358-363.e2. doi: 10.1016/j.ajo.2011.02.013. Epub 2011 Jun 17.

Abstract

PURPOSE

To identify patient characteristics influencing treatment outcomes of allograft corneal rejection.

DESIGN

Retrospective case file review.

METHODS

Files containing details of first episode of corneal allograft rejections in patients who underwent penetrating keratoplasty at the Royal Victorian Eye and Ear Hospital, Melbourne, Australia from 1991 to 2006 were reviewed. Cases were divided into 2 groups based on the response to treatment for graft rejection: treatment responders and failures. Main parameters evaluated were demographic characteristics, preoperative clinical profile, donor characteristics, surgical technique, presentation, and treatment of rejection episode.

RESULTS

A total of 235 cases of graft rejection were identified, of which 195 cases (83%) were successfully treated and 40 (17%) failed to respond. Age (P = .08) and gender (P = .61) were comparable in both groups. On univariate analysis, primary diagnosis of keratoconus (P = .04) and phakic lens status at the time of surgery (P = .02) were more common in treatment responders whereas aphakic bullous keratopathy (P ≤ .01), history of glaucoma (P < .01), aphakia (P < .01), and previous grafts (P < .01) were more common among treatment failures. Multivariate analysis revealed that preoperative corneal neovascularization (adjusted odds ratio [aOR] 3.6, 95% CI: 1.3-9.7, P = .01), a larger (>9 mm) donor size (aOR 5.7, 95% CI: 1.3-24.9, P = .02), and corneal edema at presentation (aOR 4.7, 95% CI: 1.7-13.2, P < .01), were independently associated with failure of treatment of graft rejection.

CONCLUSIONS

Treatment failure in cases of corneal allograft rejection is more likely to occur among patients with corneal neovascularization, large donor graft buttons, and corneal edema at presentation.

摘要

目的

确定影响同种异体角膜排斥反应治疗效果的患者特征。

设计

回顾性病例档案研究。

方法

回顾了 1991 年至 2006 年间在澳大利亚墨尔本皇家维多利亚眼耳医院接受穿透性角膜移植术的患者中首次发生角膜同种异体排斥反应的病例档案。根据对移植排斥反应治疗的反应,将病例分为两组:治疗反应者和治疗失败者。评估的主要参数包括人口统计学特征、术前临床特征、供体特征、手术技术、排斥反应发作的表现和治疗。

结果

共发现 235 例移植物排斥反应,其中 195 例(83%)成功治疗,40 例(17%)治疗失败。两组的年龄(P =.08)和性别(P =.61)无差异。单变量分析显示,原发性圆锥角膜诊断(P =.04)和手术时的有晶状体眼状态(P =.02)在治疗反应者中更为常见,而无晶状体疱状角膜病变(P ≤.01)、青光眼病史(P <.01)、无晶状体(P <.01)和既往移植(P <.01)在治疗失败者中更为常见。多变量分析显示,术前角膜新生血管(调整后的优势比[aOR] 3.6,95%置信区间:1.3-9.7,P =.01)、较大(>9mm)供体大小(aOR 5.7,95%置信区间:1.3-24.9,P =.02)和发作时的角膜水肿(aOR 4.7,95%置信区间:1.7-13.2,P <.01)与治疗失败的角膜移植排斥反应独立相关。

结论

角膜移植排斥反应治疗失败的可能性在有角膜新生血管、大供体移植物和发作时角膜水肿的患者中更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验